Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS
Heike Wulff, … , Christine Beeton, K. George Chandy
Heike Wulff, … , Christine Beeton, K. George Chandy
Published June 1, 2003
Citation Information: J Clin Invest. 2003;111(11):1703-1713. https://doi.org/10.1172/JCI16921.
View: Text | PDF | Erratum
Article Autoimmunity

The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS

  • Text
  • PDF
Abstract

Through a combination of fluorescence microscopy and patch-clamp analysis we have identified a striking alteration in K+ channel expression in terminally differentiated human CCR7–CD45RA– effector memory T lymphocytes (TEM). Following activation, TEM cells expressed significantly higher levels of the voltage-gated K+ channel Kv1.3 and lower levels of the calcium-activated K+ channel IKCa1 than naive and central memory T cells (TCM). Upon repeated in vitro antigenic stimulation, naive cells differentiated into Kv1.3highIKCa1low TEM cells, and the potent Kv1.3-blocking sea anemone Stichodactyla helianthus peptide (ShK) suppressed proliferation of TEM cells without affecting naive or TCM lymphocytes. Thus, the Kv1.3highIKCa1low phenotype is a functional marker of activated TEM lymphocytes. Activated myelin-reactive T cells from patients with MS exhibited the Kv1.3highIKCa1low TEM phenotype, suggesting that they have undergone repeated stimulation during the course of disease; these cells may contribute to disease pathogenesis due to their ability to home to inflamed tissues and exhibit immediate effector function. The Kv1.3highIKCa1low phenotype was not seen in glutamic acid decarboxylase, insulin-peptide or ovalbumin-specific and mitogen-activated T cells from MS patients, or in myelin-specific T cells from healthy controls. Selective targeting of Kv1.3 in TEM cells may therefore hold therapeutic promise for MS and other T cell–mediated autoimmune diseases.

Authors

Heike Wulff, Peter A. Calabresi, Rameeza Allie, Sung Yun, Michael Pennington, Christine Beeton, K. George Chandy

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 Total
Citations: 1 6 10 8 12 6 9 11 17 14 19 16 15 18 9 10 10 6 7 3 3 3 213
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (213)

Title and authors Publication Year
Identification of novel Kv1.3 channel-interacting proteins using proximity labelling in T-cells
Kour D, Bowen CA, Srivastava U, Nguyen HM, Kumari R, Kumar P, Brandelli AD, Bitarafan S, Tobin BR, Wood L, Seyfried NT, Wulff H, Rangaraju S
bioRxiv 2025
Kv1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with granulomatosis with polyangiitis.
Lintermans LL, Stegeman CA, Muñoz-Elías EJ, Tarcha EJ, Iadonato SP, Rutgers A, Heeringa P, Abdulahad WH
Rheumatology (Oxford, England) 2024
Activity of Potassium Channels in CD8(+) T Lymphocytes: Diagnostic and Prognostic Biomarker in Ovarian Cancer?
Jusztus V, Medyouni G, Bagosi A, Lampé R, Panyi G, Matolay O, Maka E, Krasznai ZT, Vörös O, Hajdu P
International journal of molecular sciences 2024
Unveiling new genetic insights in rheumatoid arthritis for drug discovery through Taxonomy3 analysis
Kozlowska J, Humphryes-Kirilov N, Pavlovets A, Connolly M, Kuncheva Z, Horner J, Manso AS, Murray C, Fox JC, McCarthy A
Scientific Reports 2024
3,3′,4,4′-tetrachlorobiphenyl (PCB77) enhances human Kv1.3 channel currents and alters cytokine production
Kim JH, Hwang S, Park SI, Lee HJ, Jung YJ, Jo SH
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 2024
Effect of Voltage-Gated K+ Channel Inhibition by 4-aminopyridine in Spinal Cord Injury Recovery in Zebrafish
Hoffman PM, Mruk K
2024
Immunomodulatory effect of Tityus sp. in mononuclear cells extracted from the blood of rheumatoid arthritis patients.
Tobar CGR, Urmendiz YDMM, Vallejo MA, Manquillo DF, Castaño VEN, Caicedo AIO, Tobar LLM, Vargas JAG, Cuellar RAD
The journal of venomous animals and toxins including tropical diseases 2024
Immune and ionic mechanisms mediating the effect of dexamethasone in severe COVID-19
Ameet Chimote, Abdulaziz Alshwimi, Martina Chirra, Vaibhavkumar Gawali, Margaret Powers-Fletcher, Kristin Hudock, Laura Conforti
Frontiers in immunology 2023
Characterization and Chemical Synthesis of Cm39 (α-KTx 4.8): A Scorpion Toxin That Inhibits Voltage-Gated K(+) Channel K(V)1.2 and Small- and Intermediate-Conductance Ca(2+)-Activated K(+) Channels K(Ca)2.2 and K(Ca)3.1.
Naseem MU, Gurrola-Briones G, Romero-Imbachi MR, Borrego J, Carcamo-Noriega E, Beltrán-Vidal J, Zamudio FZ, Shakeel K, Possani LD, Panyi G
Toxins 2023
A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis
Wang Y, Zhu D, Ortiz-Velez LC, Perry JL, Pennington MW, Hyser JM, Britton RA, Beeton C
Proceedings of the National Academy of Sciences 2023
The immunosuppressive effects and mechanisms of loureirin B on collagen-induced arthritis in rats
Zou Y, Zhao Q, Zhang X, Yu H, Zhou Y, Li Z, Xiao M, Xiang Q, Zhang L, Shi W, Tao H, Chen L, Han B, Yin S
Frontiers in immunology 2023
Inhibitory effects of N-methyl-D-aspartate (NMDA) and α(1)-adrenergic receptor antagonist ifenprodil on human Kv1.5 channel.
Hwang S, Yoon B, Jo SH
Naunyn-Schmiedeberg's Archives of Pharmacology 2023
5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human H(V)1 Channel.
Szanto TG, Feher A, Korpos E, Gyöngyösi A, Kállai J, Mészáros B, Ovari K, Lányi Á, Panyi G, Varga Z
Pharmaceuticals (Basel, Switzerland) 2023
Neural Regeneration in Dry Eye Secondary to Systemic Lupus Erythematosus Is Also Disrupted like in Rheumatoid Arthritis, but in a Progressive Fashion
Sonkodi B, Marsovszky L, Csorba A, Balog A, Kopper B, Nagy ZZ, Resch MD
International journal of molecular sciences 2023
Reduction of Ca(2+) Entry by a Specific Block of KCa3.1 Channels Optimizes Cytotoxic Activity of NK Cells against T-ALL Jurkat Cells.
Olivas-Aguirre M, Cruz-Aguilar LH, Pottosin I, Dobrovinskaya O
Cells 2023
Structure of the voltage-gated potassium channel K(V)1.3: Insights into the inactivated conformation and binding to therapeutic leads.
Chandy KG, Sanches K, Norton RS
Channels (Austin, Tex.) 2023
Dynamics and spatial organization of Kv1.3 at the immunological synapse of human CD4+ T cells
Capera J, Jainarayanan A, Navarro-Pérez M, Valvo S, Demetriou P, Depoil D, Estadella I, Kvalvaag A, Felce JH, Felipe A, Dustin ML
Biophysical Journal 2023
Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases
C Cañas, S Castaño-Valencia, F Castro-Herrera
2022
Imaging Kv1.3 Expressing Memory T Cells as a Marker of Immunotherapy Response
J Goggi, S Khanapur, B Ramasamy, S Hartimath, T Rong, P Cheng, Y Tan, X Yeo, S Jung, S Goay, S Ong, Y Hwang, K Chandy, E Robins
Cancers 2022
Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity.
Naseem MU, Carcamo-Noriega E, Beltrán-Vidal J, Borrego J, Szanto TG, Zamudio FZ, Delgado-Prudencio G, Possani LD, Panyi G
The Journal of General Physiology 2022
Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators.
Selvakumar P, Fernández-Mariño AI, Khanra N, He C, Paquette AJ, Wang B, Huang R, Smider VV, Rice WJ, Swartz KJ, Meyerson JR
Nature Communications 2022
Centipede Venom: A Potential Source of Ion Channel Modulators.
Luo A, Wang A, Kamau PM, Lai R, Luo L
International journal of molecular sciences 2022
How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity.
Chirra M, Newton HS, Gawali VS, Wise-Draper TM, Chimote AA, Conforti L
Cancers 2022
Boosting regulatory T cell function for the treatment of autoimmune diseases – That’s only half the battle!
Schlöder J, Shahneh F, Schneider FJ, Wieschendorf B
Frontiers in immunology 2022
Neurotoxins and pore forming toxins in sea anemones: Potential candidates for new drug development.
Wang ZL, Zhang SY, Hao SL, Yang WX
Histology and histopathology 2022
Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
V Hofschröer, K Najder, M Rugi, R Bouazzi, M Cozzolino, A Arcangeli, G Panyi, A Schwab
Frontiers in pharmacology 2021
Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple Sclerosis
I Markakis, I Charitakis, C Beeton, M Galani, E Repousi, S Aggeloglou, PP Sfikakis, MW Pennington, KG Chandy, C Poulopoulou
Frontiers in pharmacology 2021
Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
M Olivas-Aguirre, L Torres-López, I Pottosin, O Dobrovinskaya
Frontiers in Oncology 2021
Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
R Hirawat, MA Saifi, C Godugu
Life Sciences 2021
The voltage-gated potassium channel KV1.3 regulates neutrophil recruitment during inflammation
R Immler, W Nadolni, A Bertsch, V Morikis, I Rohwedder, S Masgrau-Alsina, T Schroll, A Yevtushenko, O Soehnlein, M Moser, T Gudermann, ER Barnea, M Rehberg, SI Simon, S Zierler, M Pruenster, M Sperandio
Cardiovascular Research 2021
Immunological Responses to Envenomation
RY Ryan, J Seymour, A Loukas, JA Lopez, MP Ikonomopoulou, JJ Miles
Frontiers in immunology 2021
Neuroprotective Properties of 4-Aminopyridine
M Dietrich, HP Hartung, P Albrecht
Neurology: Neuroimmunology & Neuroinflammation 2021
Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis
DK Singh, S Tousif, A Bhaskar, A Devi, K Negi, B Moitra, A Ranganathan, VP Dwivedi, G Das, HI Boshoff
PLoS pathogens 2021
Optimization of Pichia pastoris Expression System for High-Level Production of Margatoxin.
Naseem MU, Tajti G, Gaspar A, Szanto TG, Borrego J, Panyi G
Frontiers in pharmacology 2021
Discovery of KV 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.
Gubič Š, Hendrickx LA, Toplak Ž, Sterle M, Peigneur S, Tomašič T, Pardo LA, Tytgat J, Zega A, Mašič LP
Medicinal Research Reviews 2021
Pharmacological Approaches to Studying Potassium Channels.
Mathie A, Veale EL, Golluscio A, Holden RG, Walsh Y
Handbook of experimental pharmacology 2021
The role of the voltage-gated potassium channel, Kv2.1 in prostate cancer cell migration
Park HW, Song MS, Sim HJ, Ryu PD, Lee SY
BMB Reports 2021
Luteolin-mediated Kv1.3 K+ channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
DK Singh, VP Dwivedi, SP Singh, A Kumari, SK Sharma, A Ranganathan, LV Kaer, G Das, DM Lewinsohn
PLoS pathogens 2020
Altered Ca2+ Homeostasis in Immune Cells during Aging: Role of Ion Channels
D Zöphel, C Hof, A Lis
International journal of molecular sciences 2020
Modulation of Lymphocyte Potassium Channel K V 1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin
ST Ong, S Bajaj, MR Tanner, SC Chang, B Krishnarjuna, XR Ng, RA Morales, MW Chen, D Luo, D Patel, S Yasmin, JJ Ng, Z Zhuang, HM Nguyen, AE Sahili, J Lescar, R Patil, SA Charman, EG Robins, JL Goggi, PW Tan, P Sadasivam, B Ramasamy, SV Hartimath, V Dhawan, J Bednenko, P Colussi, H Wulff, MW Pennington, S Kuyucak, RS Norton, C Beeton, KG Chandy
2020
Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond
X Wang, G Li, J Guo, Z Zhang, S Zhang, Y Zhu, J Cheng, L Yu, Y Ji, J Tao
Frontiers in neuroscience 2020
Actions of FTY720 (Fingolimod), a Sphingosine-1-Phosphate Receptor Modulator, on Delayed-Rectifier K+ Current and Intermediate-Conductance Ca2+-Activated K+ Channel in Jurkat T-Lymphocytes
WT Chang, PY Liu, SN Wu
Molecules (Basel, Switzerland) 2020
Periodic Membrane Potential and Ca2+ Oscillations in T Cells Forming an Immune Synapse.
Papp F, Hajdu P, Tajti G, Toth A, Nagy E, Fazekas Z, Kovacs S, Vámosi G, Varga Z, Panyi G
International journal of molecular sciences 2020
Cancer-Associated Intermediate Conductance Ca2+-Activated K+ Channel KCa3.1
CJ Mohr, FA Steudel, D Gross, P Ruth, WY Lo, R Hoppe, W Schroth, H Brauch, SM Huber, R Lukowski
Cancers 2019
Critical regulation of atherosclerosis by the KCa3.1 channel and the retargeting of this therapeutic target in in-stent neoatherosclerosis
YR Zhu, XX Jiang, DM Zhang
Journal of Molecular Medicine 2019
Scorpion toxins targeting Kv1.3 channels: insights into immunosuppression
IS Oliveira, IG Ferreira, GM Alexandre-Silva, FA Cerni, CM Cremonez, EC Arantes, U Zottich, MB Pucca
Journal of Venomous Animals and Toxins 2019
KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis
MR Tanner, MW Pennington, SS Chauhan, T Laragione, PS Gulko, C Beeton
Arthritis Research & Therapy 2019
Centipede KCNQ Inhibitor SsTx Also Targets KV1.3
C Du, J Li, Z Shao, J Mwangi, R Xu, H Tian, G Mo, R Lai, S Yang
Toxins 2019
KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
E Hortle, L Starrs, F Brown, S Jane, D Curtis, BJ McMorran, SJ Foote, G Burgio
Scientific Reports 2019
Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses
S Ahmad, D Bhattacharya, S Kar, A Ranganathan, LV Kaer, G Das, S Ehrt
Infection and immunity 2019
Conformational exchange in the potassium channel blocker ShK.
Iwakawa N, Baxter NJ, Wai DCC, Fowler NJ, Morales RAV, Sugase K, Norton RS, Williamson MP
Scientific Reports 2019
Extracellular K+ Dampens T Cell Functions: Implications for Immune Suppression in the Tumor Microenvironment
Ong ST, Ng AS, Ng XR, Zhuang Z, Wong BH, Prasannan P, Kok YJ, Bi X, Shim H, Wulff H, Chandy KG, Verma NK
2019
Immunomodulation by Helminths: Intracellular Pathways and Extracellular Vesicles
A Zakeri, EP Hansen, SD Andersen, AR Williams, P Nejsum
Frontiers in immunology 2018
Diabetes Mellitus and Ischemic Heart Disease: The Role of Ion Channels
P Severino, A DAmato, L Netti, M Pucci, MD Marchis, R Palmirotta, M Volterrani, M Mancone, F Fedele
International journal of molecular sciences 2018
A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3
J Bednenko, R Harriman, L Mariën, HM Nguyen, A Agrawal, A Papoyan, Y Bisharyan, J Cardarelli, D Cassidy-Hanley, T Clark, D Pedersen, Y Abdiche, W Harriman, B van der Woning, H de Haard, E Collarini, H Wulff, P Colussi
mAbs 2018
A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis
XL Yuan, YP Zhao, J Huang, JC Liu, WQ Mao, J Yin, BW Peng, WH Liu, S Han, XH He
CNS Neuroscience & Therapeutics 2018
Kv1.3 activity perturbs the homeostatic properties of astrocytes in glioma
A Grimaldi, G DAlessandro, MA di Castro, C Lauro, V Singh, F Pagani, L Sforna, F Grassi, SD Angelantonio, L Catacuzzeno, H Wulff, C Limatola, M Catalano
Scientific Reports 2018
Kv1.3 channel blockade with the Vm24 scorpion toxin attenuates the CD4+ effector memory T cell response to TCR stimulation
JI Veytia-Bucheli, JM Jiménez-Vargas, EI Melchy-Pérez, MA Sandoval-Hernández, LD Possani, Y Rosenstein
Cell Communication and Signaling 2018
Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients
GM Diaz, J Fraussen, BV Wijmeersch, R Hupperts, V Somers
Scientific Reports 2018
Voltage Gated Potassium Channel Kv1.3 Is Upregulated on Activated Astrocytes in Experimental Autoimmune Encephalomyelitis
I Bozic, K Tesovic, D Laketa, M Adzic, M Jakovljevic, I Bjelobaba, D Savic, N Nedeljkovic, S Pekovic, I Lavrnja
Neurochemical Research 2018
Differential Activity of Voltage- and Ca2+-Dependent Potassium Channels in Leukemic T Cell Lines: Jurkat Cells Represent an Exceptional Case
S Valle-Reyes, G Valencia-Cruz, L Liñan-Rico, I Pottosin, O Dobrovinskaya
Frontiers in physiology 2018
The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo
JD Lucente, HM Nguyen, H Wulff, LW Jin, I Maezawa
Glia 2018
Differences in ion channel phenotype and function between humans and animal models.
Tanner MR, Beeton C
2018
Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept
I Maezawa, HM Nguyen, JD Lucente, DP Jenkins, V Singh, S Hilt, K Kim, S Rangaraju, AI Levey, H Wulff, LW Jin
Brain 2017
Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog
MR Tanner, RB Tajhya, R Huq, EJ Gehrmann, KE Rodarte, MA Atik, RS Norton, MW Pennington, C Beeton
Clinical Immunology 2017
GABA A receptor α 4 -subunit knockout enhances lung inflammation and airway reactivity in a murine asthma model
GT Yocum, DL Turner, J Danielsson, MB Barajas, Y Zhang, D Xu, NL Harrison, GE Homanics, DL Farber, CW Emala
American journal of physiology. Lung cellular and molecular physiology 2017
T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers
WP Fung-Leung, W Edwards, Y Liu, K Ngo, J Angsana, G Castro, N Wu, X Liu, RV Swanson, AD Wickenden, TA Baldwin
PloS one 2017
Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions
EY Chiang, T Li, S Jeet, I Peng, J Zhang, WP Lee, J DeVoss, P Caplazi, J Chen, S Warming, DH Hackos, S Mukund, CM Koth, JL Grogan
Nature Communications 2017
Mechanism of functional interaction between potassium channel Kv1.3 and sodium channel NavBeta1 subunit
T Kubota, AM Correa, F Bezanilla
Scientific Reports 2017
Helminth Immunomodulation in Autoimmune Disease
JJ Miles, TB Smallwood, PR Giacomin, A Loukas, JP Mulvenna, RJ Clark
Frontiers in immunology 2017
Direct Binding of the pH-Regulated Protein 1 (Pra1) from Candida albicans Inhibits Cytokine Secretion by Mouse CD4+ T Cells
A Bergfeld, P Dasari, S Werner, TR Hughes, WC Song, P Hortschansky, AA Brakhage, T Hünig, PF Zipfel, N Beyersdorf
Frontiers in microbiology 2017
Kv1.3 channel blocker (ImKTx88) maintains blood–brain barrier in experimental autoimmune encephalomyelitis
J Huang, S Han, Q Sun, Y Zhao, J Liu, X Yuan, W Mao, B Peng, W Liu, J Yin, X He
Cell & Bioscience 2017
A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation
S Rangaraju, SA Raza, A Pennati, Q Deng, EB Dammer, D Duong, MW Pennington, MG Tansey, JJ Lah, R Betarbet, NT Seyfried, AI Levey
Journal of Neuroinflammation 2017
Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial
EJ Tarcha, CM Olsen, P Probst, D Peckham, EJ Muñoz-Elías, JG Kruger, SP Iadonato, H Wiendl
PloS one 2017
Differentially Expressed Potassium Channels Are Associated with Function of Human Effector Memory CD8+ T Cells
JH Sim, KS Kim, H Park, KJ Kim, H Lin, TJ Kim, HM Shin, G Kim, DS Lee, CW Park, DH Lee, I Kang, SJ Kim, CH Cho, J Doh, HR Kim
Frontiers in immunology 2017
Niche-specific gene expression in a parasitic nematode; increased expression of immunomodulators in Teladorsagia circumcincta larvae derived from host mucosa
TN McNeilly, D Frew, ST Burgess, H Wright, DJ Bartley, Y Bartley, AJ Nisbet
Scientific Reports 2017
T-lymphocyte Kv1.3 channel activation triggers the NLRP3 inflammasome signaling pathway in hypertensive patients
J Zhu, Y Yang, SG Hu, QB Zhang, J Yu, YM Zhang
Experimental and therapeutic medicine 2017
KCa1.1 channels as therapeutic targets for rheumatoid arthritis
C Beeton
Expert Opinion on Therapeutic Targets 2017
Cloning, expression and identification of KTX-Sp4, a selective Kv1.3 peptidic blocker from Scorpiops pococki
Y Zou, F Zhang, Y Li, Y Wang, Y Li, Z Long, S Shi, L Shuai, J Liu, Z Di, S Yin
Cell & Bioscience 2017
Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke
YJ Chen, HM Nguyen, I Maezawa, LW Jin, H Wulff
Annals of Clinical and Translational Neurology 2017
Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant
RE Wang, Y Wang, Y Zhang, C Gabrelow, Y Zhang, V Chi, Q Fu, X Luo, D Wang, S Joseph, K Johnson, AK Chatterjee, TM Wright, VT Nguyen-Tran, J Teijaro, AN Theofilopoulos, PG Schultz, F Wang
Proceedings of the National Academy of Sciences 2016
Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of Kv1.3 channels and T cell responsiveness
T Lowinus, T Bose, S Busse, M Busse, D Reinhold, B Schraven, UH Bommhardt
Oncotarget 2016
The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke
YJ Chen, HM Nguyen, I Maezawa, EM Grössinger, AL Garing, R Köhler, LW Jin, H Wulff
Journal of Cerebral Blood Flow & Metabolism 2016
Ionic immune suppression within the tumour microenvironment limits T cell effector function
R Eil, SK Vodnala, D Clever, CA Klebanoff, M Sukumar, JH Pan, DC Palmer, A Gros, TN Yamamoto, SJ Patel, GC Guittard, Z Yu, V Carbonaro, K Okkenhaug, DS Schrump, WM Linehan, R Roychoudhuri, NP Restifo
Nature 2016
Probing pattern and dynamics of disulfide bridges using synthesis and NMR of an ion channel blocker peptide toxin with multiple diselenide bonds
K Fehér, I Timári, K Rákosi, J Szolomájer, TZ Illyés, A Bartok, Z Varga, G Panyi, GK Tóth, KE Kövér
Chemical Science 2016
The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases
F Ye, Y Hu, W Yu, Z Xie, J Hu, Z Cao, W Li, Y Wu
Toxins 2016
Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K + channel pattern in T cells
MB Pucca, TB Bertolini, FA Cerni, KC Bordon, S Peigneur, J Tytgat, VL Bonato, EC Arantes
Immunology 2016
The Role of KV7.3 in Regulating Osteoblast Maturation and Mineralization
J Yang, M Song, Y Shen, P Ryu, S Lee
International journal of molecular sciences 2016
Different expression of β subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes
Z Pethő, MR Tanner, RB Tajhya, R Huq, T Laragione, G Panyi, PS Gulko, C Beeton
Arthritis Research & Therapy 2016
Peptidomimetic Star Polymers for Targeting Biological Ion Channels
R Chen, D Lu, Z Xie, J Feng, Z Jia, J Ho, ML Coote, Y Wu, MJ Monteiro, SH Chung, AG Obukhov
PloS one 2016
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation
R Huq, EL Samuel, WK Sikkema, LG Nilewski, T Lee, MR Tanner, FS Khan, PC Porter, RB Tajhya, RS Patel, T Inoue, RG Pautler, DB Corry, JM Tour, C Beeton
Scientific Reports 2016
Differential Kv1.3, KCa3.1, and Kir2.1 expression in “classically” and “alternatively” activated microglia: Potassium Channel Expression in Microglia
HM Nguyen, EM Grössinger, M Horiuchi, KW Davis, LW Jin, I Maezawa, H Wulff
Glia 2016
Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugs
I Kazama, T Tamada
Allergy Asthma & Clinical Immunology 2016
Changes in Gene Expression and Metabolism in the Testes of the Rat following Spinal Cord Injury
RD Fortune, RJ Grill, C Beeton, M Tanner, R Huq, DS Loose
Journal of Neurotrauma 2016
Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties
IV Grishkan, DM Tosi, MD Bowman, M Harary, PA Calabresi, AR Gocke
Journal of immunology (Baltimore, Md. : 1950) 2015
Multiple Sclerosis and T Lymphocytes: An Entangled Story
L Legroux, N Arbour
Journal of Neuroimmune Pharmacology 2015
Ion Channels in Innate and Adaptive Immunity
S Feske, H Wulff, EY Skolnik
Annual Review of Immunology 2015
Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling
W Li, Z Zhang, K Zhang, Z Xue, Y Li, Z Zhang, L Zhang, C Gu, Q Zhang, J Hao, Y Da, Z Yao, Y Kong, R Zhang
Molecular Neurobiology 2015
The functional contribution of calcium ion flux heterogeneity in T cells
SN Christo, KR Diener, JD Hayball
Immunology and Cell Biology 2015
N-terminally extended analogues of the K + channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3
SC Chang, R Huq, S Chhabra, C Beeton, MW Pennington, BJ Smith, RS Norton
FEBS Journal 2015
Evidence of more ion channels inhibited by celecoxib: KV1.3 and L-type Ca2+ channels
RV Frolov, S Singh
BMC Research Notes 2015
Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK
M Pennington, S Chang, S Chauhan, R Huq, R Tajhya, S Chhabra, R Norton, C Beeton
Marine drugs 2015
Cortisone and hydrocortisone inhibit human Kv1.3 activity in a non-genomic manner
J Yu, MH Park, SY Choi, SH Jo
Naunyn-Schmiedeberg's Archives of Pharmacology 2015
Placing Ion Channels into a Signaling Network of T Cells: From Maturing Thymocytes to Healthy T Lymphocytes or Leukemic T Lymphoblasts
O Dobrovinskaya, I Delgado-Enciso, LJ Quintero-Castro, C Best-Aguilera, RM Rojas-Sotelo, I Pottosin
BioMed Research International 2015
Novel therapies for memory cells in autoimmune diseases: Novel therapies for memory cells
P Bhargava, PA Calabresi
Clinical & Experimental Immunology 2015
The C-terminus SH3-binding domain of Kv1.3 is required for the actin-mediated immobilization of the channel via cortactin
P Hajdu, GV Martin, AA Chimote, O Szilagyi, K Takimoto, L Conforti
Molecular biology of the cell 2015
Toxin acidic residue evolutionary function-guided design of de novo peptide drugs for the immunotherapeutic target, the Kv1.3 channel
Z Chen, Y Hu, J Hong, J Hu, W Yang, F Xiang, F Yang, Z Xie, Z Cao, W Li, D Lin, Y Wu
Scientific Reports 2015
Kv1.3 contains an alternative C-terminal ER exit motif and is recruited into COPII vesicles by Sec24a
JM Spear, DA Koborssy, AB Schwartz, AJ Johnson, A Audhya, DA Fadool, SM Stagg
BMC Biochemistry 2015
Toxins Targeting the KV1.3 Channel: Potential Immunomodulators for Autoimmune Diseases
Y Zhao, J Huang, X Yuan, B Peng, W Liu, S Han, X He
Toxins 2015
Lack of effect of Z-butylidenephthalide on presynaptic N-type Ca2+ channels in isolated guinea-pig ileum
M Chen, WC Ko
Naunyn-Schmiedeberg's Archives of Pharmacology 2015
Inhibition of Kv channel expression by NSAIDs depolarizes membrane potential and inhibits cell migration by disrupting calpain signaling
K Silver, A Littlejohn, L Thomas, E Marsh, JD Lillich
Biochemical Pharmacology 2015
An engineered scorpion toxin analogue with improved Kv1.3 selectivity displays reduced conformational flexibility
A Bartok, K Fehér, A Bodor, K Rákosi, GK Tóth, KE Kövér, G Panyi, Z Varga
Scientific Reports 2015
State-dependent blocking mechanism of K v 1.3 channels by the antimycobacterial drug clofazimine: State-dependent block of Kv1.3 by clofazimine
M Faouzi, J Starkus, R Penner
British Journal of Pharmacology 2015
Mutational Consequences of Aberrant Ion Channels in Neurological Disorders
D Kumar, RK Ambasta, P Kumar
The Journal of Membrane Biology 2014
Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis
LK Hansen, L Sevelsted-Møller, M Rabjerg, D Larsen, TP Hansen, L Klinge, H Wulff, T Knudsen, J Kjeldsen, R Köhler
Journal of Crohn's and Colitis 2014
Kcnn4 Is a Regulator of Macrophage Multinucleation in Bone Homeostasis and Inflammatory Disease
H Kang, A Kerloc’h, M Rotival, X Xu, Q Zhang, Z D’Souza, M Kim, JC Scholz, JH Ko, PK Srivastava, JR Genzen, W Cui, TJ Aitman, L Game, JE Melvin, A Hanidu, J Dimock, J Zheng, D Souza, AK Behera, G Nabozny, HT Cook, JH Bassett, GR Williams, J Li, A Vignery, E Petretto, J Behmoaras
Cell Reports 2014
Loureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cells
S Yin, Q Hu, J Luo, Y Li, C Lu, X Chen, H Hu
Cell & Bioscience 2014
Ion channels and anti-cancer immunity
G Panyi, C Beeton, A Felipe
Philosophical Transactions of the Royal Society B: Biological Sciences 2014
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases
MH Rashid, R Huq, MR Tanner, S Chhabra, KK Khoo, R Estrada, V Dhawan, S Chauhan, MW Pennington, C Beeton, S Kuyucak, RS Norton
Scientific Reports 2014
Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review
RJ Bright, J Wilkinson, BJ Coventry
BMC neurology 2014
Electrophysiological Characterization of Ts6 and Ts7, K+ Channel Toxins Isolated through an Improved Tityus serrulatus Venom Purification Procedure
F Cerni, M Pucca, S Peigneur, C Cremonez, K Bordon, J Tytgat, E Arantes
Toxins 2014
Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis – Xenograft model
S Kundu-Raychaudhuri, YJ Chen, H Wulff, SP Raychaudhuri
Journal of Autoimmunity 2014
Oxidative Modulation of Voltage-Gated Potassium Channels
N Sahoo, T Hoshi, SH Heinemann
Antioxidants & Redox Signaling 2014
T Cells in Vascular Inflammatory Diseases
LL Lintermans, CA Stegeman, P Heeringa, WH Abdulahad
Frontiers in immunology 2014
The CNS under pathophysiologic attack—examining the role of K2P channels
P Ehling, M Cerina, T Budde, SG Meuth, S Bittner
Pflügers Archiv - European Journal of Physiology 2014
Binding Modes of Two Scorpion Toxins to the Voltage-Gated Potassium Channel Kv1.3 Revealed from Molecular Dynamics
R Chen, SH Chung
Toxins 2014
Physiological Role of Kv1.3 Channel in T Lymphocyte Cell Investigated Quantitatively by Kinetic Modeling
P Hou, R Zhang, Y Liu, J Feng, W Wang, Y Wu, J Ding, SE Dryer
PloS one 2014
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases
S Chhabra, SC Chang, HM Nguyen, R Huq, MR Tanner, LM Londono, R Estrada, V Dhawan, S Chauhan, SK Upadhyay, M Gindin, PJ Hotez, JG Valenzuela, B Mohanty, JD Swarbrick, H Wulff, SP Iadonato, GA Gutman, C Beeton, MW Pennington, RS Norton, KG Chandy
The FASEB Journal 2014
Blocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma
S Koshy, R Huq, MR Tanner, MA Atik, PC Porter, FS Khan, MW Pennington, NA Hanania, DB Corry, C Beeton
The Journal of biological chemistry 2014
Autoimmune effector memory T cells: the bad and the good
P Devarajan, Z Chen
Immunologic Research 2013
The Potassium Channel KCa3.1 as New Therapeutic Target for the Prevention of Obliterative Airway Disease:
X Hua, T Deuse, YJ Chen, H Wulff, M Stubbendorff, R Köhler, H Miura, F Länger, H Reichenspurner, RC Robbins, S Schrepfer
Transplantation 2013
The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy
YJ Chen, J Lam, CR Gregory, S Schrepfer, H Wulff
PloS one 2013
Blockade of KCa3.1 Ameliorates Renal Fibrosis Through the TGF- 1/Smad Pathway in Diabetic Mice
C Huang, S Shen, Q Ma, J Chen, A Gill, CA Pollock, XM Chen
Diabetes 2013
Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes
S Koshy, D Wu, X Hu, RB Tajhya, R Huq, FS Khan, MW Pennington, H Wulff, P Yotnda, C Beeton
PloS one 2013
Potent Suppression of Kv1.3 Potassium Channel and IL-2 Secretion by Diphenyl Phosphine Oxide-1 in Human T Cells
N Zhao, Q Dong, LL Du, XX Fu, YM Du, YH Liao, X Chen
PloS one 2013
Functionalized liposomes loaded with siRNAs targeting ion channels in effector memory T cells as a potential therapy for autoimmunity
P Hajdu, AA Chimote, TH Thompson, Y Koo, Y Yun, L Conforti
Biomaterials 2013
Derivation of Neural Stem Cells from Human Adult Peripheral CD34+ Cells for an Autologous Model of Neuroinflammation
T Wang, E Choi, MC Monaco, E Campanac, M Medynets, T Do, P Rao, KR Johnson, AG Elkahloun, GV Geldern, T Johnson, S Subramaniam, D Hoffman, E Major, A Nath, W Hu
PloS one 2013
A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental Confirmation
MH Rashid, G Heinzelmann, R Huq, RB Tajhya, SC Chang, S Chhabra, MW Pennington, C Beeton, RS Norton, S Kuyucak, A Cavalli
PloS one 2013
Modulation of T Lymphocyte Calcium Influx Patterns Via the Inhibition of Kv1.3 and Ikca1 Potassium Channels in Autoimmune Disorders
C Orbán, E Biró, E Grozdics, A Bajnok, G Toldi
Frontiers in immunology 2013
KCa3.1 Channel-Blockade Attenuates Airway Pathophysiology in a Sheep Model of Chronic Asthma
JV der Velden, G Sum, D Barker, E Koumoundouros, G Barcham, H Wulff, N Castle, P Bradding, K Snibson, M Idzko
PloS one 2013
Expression of Kv1.3 potassium channels regulates density of cortical interneurons: Kv1.3 Regulates Cortical Interneurons
A Duque, VR Gazula, LK Kaczmarek
Developmental Neurobiology 2013
HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity
J Liu, P Xu, C Collins, H Liu, J Zhang, JP Keblesh, H Xiong, ML Block
PloS one 2013
Computational Studies of Marine Toxins Targeting Ion Channels
M Rashid, S Mahdavi, S Kuyucak
Marine drugs 2013
Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes
L Hu, T Wang, AR Gocke, A Nath, H Zhang, JB Margolick, KA Whartenby, PA Calabresi, JX Gao
PloS one 2013
Kv1.3 deletion biases T cells towards an immuno-regulatory phenotype and renders mice resistant to autoimmune encephalomyelitis1
AR Gocke, LA Lebson, IV Grishkan, L Hu, HM Nguyen, KA Whartenby, KG Chandy, PA Calabresi
Journal of immunology (Baltimore, Md. : 1950) 2012
The Antibody Targeting the E314 Peptide of Human Kv1.3 Pore Region Serves as a Novel, Potent and Specific Channel Blocker
XF Yang, Y Yang, YT Lian, ZH Wang, XW Li, LX Cheng, JP Liu, YF Wang, X Gao, YH Liao, M Wang, QT Zeng, K Liu, SG Meuth
PloS one 2012
Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL
Y Yang, YF Wang, XF Yang, ZH Wang, YT Lian, Y Yang, XW Li, X Gao, J Chen, YW Shu, LX Cheng, YH Liao, K Liu
Journal of lipid research 2012
Conotoxins that Confer Therapeutic Possibilities
M Essack, VB Bajic, JA Archer
Marine drugs 2012
Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease
I Maezawa, DP Jenkins, BE Jin, H Wulff
International Journal of Alzheimer's Disease 2012
Selective inhibition of CCR7(-) effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model
Z Li, WH Liu, S Han, BW Peng, J Yin, YL Wu, XH He, WX Li
The Journal of biological chemistry 2012
KCa3.1 and TRPM7 Channels at the Uropod Regulate Migration of Activated Human T Cells
Z Kuras, YH Yun, AA Chimote, L Neumeier, L Conforti
PloS one 2012
Ion channels and transporters in lymphocyte function and immunity
S Feske, EY Skolnik, M Prakriya
Nature Reviews Immunology 2012
Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors
LH Wang, N Wang, XY Lu, BC Liu, MK Yanda, JZ Song, HM Dai, YL Sun, HF Bao, DC Eaton, HP Ma
2012
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria
SC Chang, CA Galea, EW Leung, RB Tajhya, C Beeton, MW Pennington, RS Norton
Toxicon 2012
Protective Roles for Potassium SK/KCa2 Channels in Microglia and Neurons
AM Dolga, C Culmsee
Frontiers in pharmacology 2012
A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3
MW Pennington, MH Rashid, RB Tajhya, C Beeton, S Kuyucak, RS Norton
FEBS Letters 2012
Modeling and Simulation of Ion Channels
C Maffeo, S Bhattacharya, J Yoo, D Wells, A Aksimentiev
Chemical Reviews 2012
Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease
EJ Tarcha, V Chi, EJ Munoz-Elias, D Bailey, LM Londono, SK Upadhyay, K Norton, A Banks, I Tjong, H Nguyen, X Hu, GW Ruppert, SE Boley, R Slauter, J Sams, B Knapp, D Kentala, Z Hansen, MW Pennington, C Beeton, KG Chandy, SP Iadonato
The Journal of pharmacology and experimental therapeutics 2012
Vm24, a Natural Immunosuppressive Peptide, Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells
Z Varga, G Gurrola-Briones, F Papp, RC de la Vega, G Pedraza-Alva, RB Tajhya, R Gaspar, L Cardenas, Y Rosenstein, C Beeton, LD Possani, G Panyi
Molecular pharmacology 2012
K+ channel alterations in the progression of experimental autoimmune encephalomyelitis
PI Jukkola, AE Lovett-Racke, SS Zamvil, C Gu
Neurobiology of Disease 2012
Modulation of T cell activation by localized K+ accumulation at the immunological synapse—A mathematical model
GV Martin, Y Yun, L Conforti
Journal of Theoretical Biology 2012
KCa1.1 Potassium Channels Regulate Key Proinflammatory and Invasive Properties of Fibroblast-like Synoviocytes in Rheumatoid Arthritis
X Hu, T Laragione, L Sun, S Koshy, KR Jones, II Ismailov, P Yotnda, FT Horrigan, PS Gulko, C Beeton
The Journal of biological chemistry 2012
A Human-Mouse Chimeric Model of Obliterative Bronchiolitis after Lung Transplantation
J Xue, X Zhu, MP George, MM Myerburg, MW Stoner, JW Pilewski, SR Duncan
The American Journal of Pathology 2011
Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models
LT Mars, P Saikali, RS Liblau, N Arbour
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011
The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression
J Lam, H Wulff
Drug Development Research 2011
Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis
CL Pittet, J Newcombe, A Prat, N Arbour
Journal of Neuroinflammation 2011
Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
V Chi, MW Pennington, RS Norton, EJ Tarcha, LM Londono, B Sims-Fahey, SK Upadhyay, JT Lakey, S Iadonato, H Wulff, C Beeton, KG Chandy
Toxicon 2011
Influence of Specific Immunotherapy on the Activity of Human T Lymphocyte Kv1.3 Voltage-Gated Potassium Channels in Insect Venom Allergic Patients
M Nittner-Marszalska, A Teisseyre, B Jaźwiec, A Kowal, M Wujczyk, A Gawlik, M Krasnowska
The Journal of Membrane Biology 2011
Modeling the Binding of Three Toxins to the Voltage-Gated Potassium Channel (Kv1.3)
R Chen, A Robinson, D Gordon, SH Chung
Biophysical Journal 2011
Functional Blockade of the Voltage-gated Potassium Channel Kv1.3 Mediates Reversion of T Effector to Central Memory Lymphocytes through SMAD3/p21cip1 Signaling
L Hu, AR Gocke, E Knapp, JM Rosenzweig, IV Grishkan, EG Baxi, H Zhang, JB Margolick, KA Whartenby, PA Calabresi
The Journal of biological chemistry 2011
Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases.
Beeton C, Pennington MW, Norton RS
Inflammation & allergy drug targets 2011
Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis
L Di, S Srivastava, O Zhdanova, Y Ding, Z Li, H Wulff, M Lafaille, EY Skolnik
Proceedings of the National Academy of Sciences 2010
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840
H Wulff
Expert Opinion on Therapeutic Patents 2010
Selected MicroRNAs Define Cell Fate Determination of Murine Central Memory CD8 T Cells
G Almanza, A Fernandez, S Volinia, X Cortez-Gonzalez, CM Croce, M Zanetti, D Unutmaz
PloS one 2010
Natural products and ion channel pharmacology
RW Teichert, BM Olivera
Future Medicinal Chemistry 2010
Therapeutic potential of KCa3.1 blockers: an overview of recent advances, and promising trends
H Wulff, NA Castle
Expert Review of Clinical Pharmacology 2010
Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers
A Cheong, J Li, P Sukumar, B Kumar, F Zeng, K Riches, C Munsch, IC Wood, KE Porter, DJ Beech
Cardiovascular Research 2010
Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis
T Hyodo, T Oda, Y Kikuchi, K Higashi, T Kushiyama, K Yamamoto, M Yamada, S Suzuki, R Hokari, M Kinoshita, S Seki, H Fujinaka, T Yamamoto, S Miura, H Kumagai
AJP Renal Physiology 2010
From the Background to the Spotlight: TASK Channels in Pathological Conditions: TASK Channels in Pathology
S Bittner, T Budde, H Wiendl, SG Meuth
Brain Pathology 2010
Nucleoside Diphosphate Kinase B Knock-out Mice Have Impaired Activation of the K+ Channel KCa3.1, Resulting in Defective T Cell Activation
L Di, S Srivastava, O Zhdanova, Y Sun, Z Li, EY Skolnik
The Journal of biological chemistry 2010
Use of Kv1.3 blockers for inflammatory skin conditions.
Nguyen W, Howard BL, Neale DS, Thompson PE, White PJ, Wulff H, Manallack DT
Current medicinal chemistry 2010
TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system
S Bittner, SG Meuth, K Göbel, N Melzer, AM Herrmann, OJ Simon, A Weishaupt, T Budde, DA Bayliss, M Bendszus, H Wiendl
Brain : a journal of neurology 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Voltage-gated potassium channels as therapeutic targets
H Wulff, NA Castle, LA Pardo
Nature Reviews Drug Discovery 2009
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes
MW Pennington, C Beeton, CA Galea, BJ Smith, V Chi, KP Monaghan, A Garcia, S Rangaraju, A Giuffrida, D Plank, G Crossley, D Nugent, I Khaytin, Y Lefievre, I Peshenko, C Dixon, S Chauhan, A Orzel, T Inoue, X Hu, RV Moore, RS Norton, KG Chandy
Molecular pharmacology 2009
The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy
P Bradding, H Wulff
British Journal of Pharmacology 2009
The functional network of ion channels in T lymphocytes
MD Cahalan, KG Chandy
Immunological Reviews 2009
Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures
RP Lisak, JA Benjamins, B Bealmear, L Nedelkoska, D Studzinski, E Retland, B Yao, S Land
Journal of Neuroinflammation 2009
Blockade of T-Lymphocyte KCa3.1 and Kv1.3 Channels as Novel Immunosuppression Strategy to Prevent Kidney Allograft Rejection
I Grgic, H Wulff, I Eichler, C Flothmann, R Köhler, J Hoyer
Transplantation Proceedings 2009
Formulation-based approach to support early drug discovery and development efforts: a case study with enteric microencapsulation dosage form development for a triarylmethane derivative TRAM-34; a novel potential immunosuppressant
AM Al-Ghananeem, M Abbassi, S Shrestha, G Raman, H Wulff , L Pereira, A Ansari
Drug Development and Industrial Pharmacy 2009
The Class II Phosphatidylinositol 3 kinase C2β Is Required for the Activation of the K + Channel KCa3.1 and CD4 T-Cells
S Srivastava, L Di, O Zhdanova, Z Li, S Vardhana, Q Wan, Y Yan, R Varma, J Backer, H Wulff, ML Dustin, EY Skolnik, CH Heldin
Molecular biology of the cell 2009
Role of the Intermediate-conductance Calcium-activated Potassium Channels, KCa3.1, in Cellular Activation and Atherogenesis
Kazuyoshi Toyama, Heike Wulff, K. George Chandy, Philippe Azam, Girija Raman, Takashi Saito, Yoshimasa Fujiwara, David L. Mattson, Satarupa Das, James E. Melvin, Phillip F. Pratt, Ossama A. Hatoum, David D. Gutterman, David R. Harder, Hiroto Miura
Journal of Clinical Investigation 2008
Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes
YR Ren, F Pan, S Parvez, A Fleig, CR Chong, J Xu, Y Dang, J Zhang, H Jiang, R Penner, JO Liu
PloS one 2008
K + Channel Modulators for the Treatment of Neurological Disorders and Autoimmune Diseases
H Wulff, BS Zhorov
Chemical Reviews 2008
Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block
MP Matheu, C Beeton, A Garcia, V Chi, S Rangaraju, O Safrina, K Monaghan, MI Uemura, D Li, S Pal, LM de la Maza, E Monuki, A Flügel, MW Pennington, I Parker, KG Chandy, MD Cahalan
Immunity 2008
4-Phenoxybutoxy-substituted heterocycles--a structure-activity relationship study of blockers of the lymphocyte potassium channel Kv1.3
SB Bodendiek, C Mahieux, W Hänsel, H Wulff
European Journal of Medicinal Chemistry 2008
Study of membrane potential in T lymphocytes subpopulations using flow cytometry
FM de Queiroz, CG Ponte, A Bonomo, R Vianna-Jorge, G Suarez-Kurtz
BMC Immunology 2008
Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis
P Azam, A Sankaranarayanan, D Homerick, S Griffey, H Wulff
Journal of Investigative Dermatology 2007
Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques
LE Pereira, F Villinger, H Wulff, A Sankaranarayanan, G Raman, AA Ansari
Experimental biology and medicine (Maywood, N.J.) 2007
Presence of HSV-1 Immediate Early Genes and Clonally Expanded T-cells with a Memory Effector Phenotype in Human Trigeminal Ganglia
T Derfuss, S Segerer, S Herberger, I Sinicina, K Hüfner, K Ebelt, HG Knaus, I Steiner, E Meinl, K Dornmair, V Arbusow, M Strupp, T Brandt, D Theil
Brain Pathology 2007
The Ca2+-Activated K+ Channel KCNN4/KCa3.1 Contributes to Microglia Activation and Nitric Oxide-Dependent Neurodegeneration
V Kaushal, PD Koeberle, Y Wang, LC Schlichter
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007
Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.
Nicolaou SA, Szigligeti P, Neumeier L, Lee SM, Duncan HJ, Kant SK, Mongey AB, Filipovich AH, Conforti L
Journal of immunology (Baltimore, Md. : 1950) 2007
Possible mechanisms of the formation of chronic fatigue syndrome in the clinical picture of multiple sclerosis.
Kasatkin DS, Spirin NN
Neuroscience and Behavioral Physiology 2007
Multiple sclerosis and headache co-morbidity. A case-control study.
Vacca G, Marano E, Brescia Morra V, Lanzillo R, De Vito M, Parente E, Orefice G
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2007
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
C Beeton, H Wulff, NE Standifer, P Azam, KM Mullen, MW Pennington, A Kolski-Andreaco, E Wei, A Grino, DR Counts, PH Wang, CJ LeeHealey, BS Andrews, A Sankaranarayanan, D Homerick, WW Roeck, J Tehranzadeh, KL Stanhope, P Zimin, PJ Havel, S Griffey, HG Knaus, GT Nepom, GA Gutman, PA Calabresi, KG Chandy
Proceedings of the National Academy of Sciences 2006
The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes
SA Nicolaou, L Neumeier, Y Peng, DC Devor, L Conforti
American journal of physiology. Cell physiology 2006
Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells
S Srivastava, K Ko, P Choudhury, Z Li, AK Johnson, V Nadkarni, D Unutmaz, WA Coetzee, EY Skolnik
Molecular and cellular biology 2006
Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases
C Beeton
Molecular pharmacology 2005
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain
H Rus, CA Pardo, L Hu, E Darrah, C Cudrici, T Niculescu, F Niculescu, KM Mullen, R Allie, L Guo, H Wulff, C Beeton, SI Judge, DA Kerr, HG Knaus, KG Chandy, PA Calabresi
Proceedings of the National Academy of Sciences 2005
Hypoxia modulates early events in T cell receptor-mediated activation in human T lymphocytes via Kv1.3 channels: Functional consequences of Kv1.3 channel inhibition during hypoxia in CD3 + cells
JR Robbins, SM Lee, AH Filipovich, P Szigligeti, L Neumeier, M Petrovic, L Conforti
The Journal of Physiology 2005
K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom
S Mouhat, V Visan, S Ananthakrishnan, H Wulff, N Andreotti, S Grissmer, H Darbon, MD Waard, JM Sabatier
Biochemical Journal 2004
K+ channels as targets for specific immunomodulation
KG Chandy, H Wulff, C Beeton, M Pennington, GA Gutman, MD Cahalan
Trends in Pharmacological Sciences 2004
Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells
G Panyi, G Vámosi, Z Bacsó, M Bagdány, A Bodnár, Z Varga, R Gáspár, L Mátyus, S Damjanovich
Proceedings of the National Academy of Sciences 2004

← Previous 1 2 3 … 8 9 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts